Portal hypertensive gastropathy is a vascular disorder of the gastric mucosa distinguished by ectasia of the mucosal capillaries and submucosal veins without inflammation. During 1988 to 1993, 12 patients with biopsyproven cirrhosis (10 alcoholic, 2 posthepatitic) were evaluated and treated prospectively by portacaval shunt for active bleeding from severe portal hypertensive gastropathy. Eleven patients had been hospitalized for bleeding three to nine times previously, and one was bleeding uncontrollably for the first time. Requirement for blood transfusions ranged from 11 The pathophysiolgy of PHG is distinct from that of gastritis [2] , although the earliest reports of portal decompression to treat PHG referred to it as "erosive gastritis" or "hemorrhagic gastritis" for want of a better term [5] [6] [7] . Subsequent investigations have shown that the pathogenesis of PHG is a consequence of adverse events in the gastric mucosal microvasculature [8] [9] [10] hemor- rhage. Implicit in this scheme is that patients also are afforded prompt, definitive airway control, ongoing fluid resuscitation, correction of coagulopathy, and maintenance of normothermia. In an editorial accompanying Orloff's paper, Conn 14] suggests that the speed with which the UCSD team addresses the physiologic derangement of severe portal hypertensive bleeding may be the most significant aspect of treatment. We agree. While 
